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Introduction
Alzheimer's disease (AD), the most common type of age-related dementia, is characterized by memory deterioration and behavior disorder. The World Alzheimer Report 2016 estimated that there were 46.8 million people worldwide living with dementia in 2015 and this number will reach 131.5 million in 2050. Histopathological features of AD include the presence of extracellular deposits of b-amyloid peptides (plaques) and intracellular aggregates of the microtubule binding protein tau (tangles), which form the two distinguishing hallmark pathological features of AD.
1 Moreover, one of the strongest risk factors for the AD is brain aging.
2 Reactive oxygen species (ROS) and oxidative stress are known to be associated with several ageassociated neuronal disorders. D-galactose (D-gal) is a physiological nutrient; however, accumulated D-gal in vivo is metabolized by D-gal oxidases, which is accompanied by H 2 O 2 generation, resulting in an increased oxidative damage. 3 Moreover, a growing body of evidence indicates that D-gal overdose in animals causes neurotoxicity including oxidative stress, neuronal apoptosis, and astrocyte activation. 4 Therefore, injection of D-gal is a model for brain aging, which induces and accelerates senescence in rodents to develop AD-like symptoms.
5
The Shunaoxin dropping pill (SNX) is derived from a traditional recipe, which is composed of 2 herbs: Chuanxiong (Ligusticum chuanxiong Hort, Umbelliferae) and Danggui (Angelica sinensis radix, Umbelliferae). Both Chuanxiong and Danggui have been widely used in China, Japan, Korea, and other Asian countries for centuries. SNX is produced by supercritical uid extraction as a solid dispersion and has been used to treat cerebrovascular diseases in China since 2005 (approval number Z20050041). Our previous research demonstrated that the six major chemical compounds in SNX extract were ferulic acid, senkyunolide H, senkyunolide I, senkyunolide A, ligustilide, and levistolide A. 6 Moreover, our previous results suggested that ligustilide-rich total lactones derived from the Shunaoxin dropping pill could alleviate the cognition decline triggered by diabetes. 7 The reported studies showed that ligustilide exerted neuroprotective effects against ischemia/reperfusion-induced brain injury by minimizing oxidative stress and antiapoptosis. 8, 9 Ligustilide inhibits Ab1-40 toxicity on PC12 cells and ameliorates memory impairment induced by scopolamine in mice.
10 This compound could be developed into a therapeutic agent to prevent and treat ischaemic disorders. In addition, ferulic acid inhibits Ab1-40 toxicity on PC12 cells, provides neuroprotection against oxidative stress-related apoptosis aer cerebral ischemia/reperfusion injury in rats, and ameliorates memory impairment in a D-gal-induced aging mouse model.
11,12
Therefore, we suspect that SNX has a neuroprotective effect. In this study, we used an in vitro H 2 O 2 -induced PC12 cell oxidative damage model and an in vivo D-gal-induced mouse memory impairment model to investigate whether SNX had neuroprotective effects.
Materials and methods

Materials
SNX was obtained from Zhongxin Pharmaceuticals (Tianjin, China). D-gal and vitamin E (VE) were purchased from YiFang Technology Co., Ltd. (Tianjin, China). Donepezil (DON) was purchased from a drug store (Tianjin, China). Malondialdehyde (MDA), superoxide dismutase (SOD), glutathione (GSH), and glutathione peroxidase (GPx) assay kits were obtained from Nanjing Jiancheng Bioengineering Research Institute (Nanjing, China). Anti-cleaved caspase-3, anti-nuclear factor kB (NF-kB), and anti-glial brillary acidic protein (GFAP) antibodies were purchased from Boster Biological Engineering Co., Ltd. (Wuhan, China). Biotinylated goat anti-rabbit secondary antibody and 3,3 0 -diaminobenzidine tetrahydrochloride (DAB) were purchased from ZSGB-BIO (Beijing, China). The other reagents were commercially available and of analytical purity.
Neuroprotective effects of SNX on H 2 O 2 -induced cytotoxicity
Cell culture. PC12 cells, a rat cell line derived from pheochromocytoma cells, were acquired from the Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (Shanghai, China), and were maintained on tissue culture plastic in an RPMI-1640 medium supplemented with 10% fetal bovine serum at 37 C under an atmosphere of 5% CO 2 and 95% air. Cell viability assay. Cell proliferation was measured by the colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The amount of formazan was measured at 570 nm using a 96-well plate reader (BioTek Instruments, Inc.). Briey, the cells were seeded at a density of 5 Â 10 5 per well in the 96-well plates. Prior to exposure to 100 mM H 2 O 2 for 2 h, PC12 cells were pre-treated with SNX (50 mg mL
À1
) for 24 h. Aer this, 200 mM vitamin E was used as a positive control. Then, a fresh solution of MTT (0.5 mg mL
) was added to each well with further incubation for 4 h. Finally, the cells were dissolved with 100 mL of DMSO and then analyzed in a multiwell plate reader at 570 nm.
Nuclear staining for the assessment of apoptosis. Chromosomal condensation and morphological changes in the nucleus of PC12 cells were observed using the chromatin dye Hoechst 33258. The PC12 cells were xed with 100% ice-cold methyl alcohol for 10 min. Aer washing with phosphate buffer saline (PBS) three times, the nuclei were stained with 5 mg mL À1 of Hoechst 33258 for 15 min and then observed using a uores-cence microscope equipped with UV lters. 
1).
Morris water maze test. Aer the SNX treatment, mice (n ¼ 12 each group) were subjected to the Morris water maze test as described previously.
13 Briey, the experimental apparatus consisted of a circular pool lled with water (23 AE 1 C). A platform was located 1 cm below the water surface at the center of the target quadrant, providing the only escape from water. During 6 days of training, the mice underwent 4 trials a day, alternating among 4 pseudorandom starting points. If a mouse failed to nd the platform within 90 s, it was guided to the platform by the researcher and kept there for 15 s. Probe trials were conducted 24 h aer the last training trial. During the probe trials, the platform was removed, and the mice were free to swim in the tank for 90 s. The training and probe trials were recorded by a video camera mounted on the ceiling, and data were analyzed using the behavior analyzing system (Anhui Zhenghua Biological Equipment Co., Ltd, Anhui, China). This system was used to record the swimming trace and calculate the latency to the platform and platform crossing times. The number of times that the mice crossed the position where the platform was placed during the learning session (crossing times) and the time required to locate the hidden escape platform (escape latency) were determined using the behavior analyzing system.
Immunohistochemistry. For immunohistochemistry, endogenous peroxidase activity in the sectioned tissues was blocked with 3% H 2 O 2 , and nonspecic binding sites were blocked with 3% normal goat serum (ZSGB-BIO, Beijing, China). Aer blocking, the sectioned tissues were incubated overnight in rabbit anticleaved caspase-3, anti-NF-kB, and anti-GFAP antibodies (Boster Biological Engineering Co., Ltd. Wuhan, China) diluted 1 : 100 in the blocking solution. Following incubation with the primary antibody, the sections were incubated for 1 h in biotinylated goat anti-rabbit secondary antibody diluted 1 : 500 in PBS and subsequently incubated with an avidin-biotin-horseradish peroxidase complex for 15 min at 37 C. The sections were washed twice with PBS and incubated in DAB, and then, the sections were washed with distilled water. The staining of caspase-3, NF-kB, and GFAP proteins were measured using the Image Pro Plus soware (IPP 6.0, Media Cybernetics). Brown staining on the cell membrane or in the cytoplasm represented positive staining, and the staining density indicated the expression levels of caspase-3, NF-kB, and GFAP proteins. Histopathological analysis. Brain tissues from each group were xed in a 4% paraformaldehyde solution for 24 h. Aer routine tissue processing, the tissues were embedded in paraffin. Then, 4 mm-thick sections obtained from each paraffin block were stained with hematoxylin and eosin (HE) and Nissl staining for histopathological evaluation. Images were obtained using a digital camera (ECLIPSE TS 100, Nikon) and analyzed using IPP 6.0.
Statistical analysis. All values are expressed as means AE standard errors (s.e.). Data were analyzed by one-way analysis of variance (ANOVA), and differences among means were analyzed using the Dunnett's test or Fisher's Protected LSD multiple comparison test. Tests were performed using the SPSS 20.0 system (Chicago, IL); a P value less than or equal to 0.05 was considered to be statistically signicant.
Results
SNX improved the viability of PC12 cells damaged by H 2 O 2
To verify the cytotoxic and neuroprotective effects of SNX for H 2 O 2 -induced PC12 cell oxidative injury, a cell viability assay was performed by the MTT method. The results indicate that SNX has no signicant cytotoxicity (data not shown herein). As Fig. 2 illustrates, the cell viability was markedly decreased in PC12 cells damaged by H 2 O 2 , whereas SNX effectively protected the cells as compared to those in the model.
SNX prevented apoptosis in PC12 cells induced by H 2 O 2
We observed the effect of SNX on the morphology of PC12 cells treated with H 2 O 2 . The PC12 cells in the control group grew well and maintained normal cell morphology (Fig. 3A) . However, exposure to H 2 O 2 for 2 h resulted in an obvious reduction in the number of viable cells and cell body shrinkage and disruption of the dendritic networks (Fig. 3A) . However, cells in cultures pre-treated with SNX displayed normal morphology without remarkable cell number reduction and cell congregation.
The morphological changes were further conrmed using the DNA uorescent dye Hoechst 33258. As illustrated in Fig. 3B , cells in the control group exhibited a high rate of healthy nuclei. However, cells treated with H 2 O 2 alone contained a lot of small bright blue dots, representing chromatin condensation or nuclear fragmentation. Pretreatment with SNX could reverse these abnormalities, and a signicant decrease in nuclear condensation and fragmentation was observed.
SNX improved learning and memory of D-gal treated mice
To investigate the effect of D-gal and SNX on mice behavior and memory function, the Morris water maze test was performed. As shown in Fig. 4A , the escape latency declined progressively during the 6 training days. Moreover, the escape latency in the D-gal group was much longer than that in the other groups for all training days. These results revealed that the D-gal-treated mice had signicant memory impairment. Aer the trial session on day 7, the hidden platform was removed, and the probe test was performed. As illustrated in Fig. 4B and C, the number of platform crossings and the time spent in the target quadrant were signicantly increased by SNX treatment in the Dgal-treated mice as compared to those in the case of the D-gal- alone-treated mice. Compared with the vehicle control group, Dgal-alone-treated mice spent less time (P < 0.05) in the target quadrant and crossed to the platform fewer times (P < 0.05). Interestingly, there was a signicant difference between the SNX-treated groups and the D-gal-alone-treated group, indicating that SNX could restore the D-gal-induced decit of memory and learning ability. In addition, the swimming speed of the mice in the model group was lower than that in mice in the other groups, but there was no signicant difference (data was not presented).
SNX alleviated oxidative stress in the brain of D-gal-treated mice
We have further examined several key antioxidants, including the enzymatic antioxidants SOD and GPx, which can scavenge ROS, GSH levels in the brain of D-gal-induced mice, and the oxidative stress-induced MDA levels. As illustrated in Table 1 , compared to the control group, mice treated with D-gal showed a signicant decrease in the content of GSH, activities of SOD, and GPx, whereas the MDA level was signicantly increased (P < 0.05). Administration of SNX resulted in antioxidant effects in Dgal-treated mice, as evidenced by an increase in the GSH content, SOD and GPx activities along with a decline of the MDA level in D-gal-alone-treated mice.
SNX attenuated the caspase-3 protein expression in the hippocampus of D-gal-treated mice
To further investigate the neuroprotective mechanism of SNX, we observed the effect of SNX on the expression of caspase-3 protein in the CA1 region of the hippocampus through immunohistochemistry. The results shown in Fig. 5 demonstrated that D-gal treatment induced an increase in the activation of caspase-3 in the CA1 region of the hippocampus that was reversed by SNX, and a decrease in the number of active caspase-3-positive cells as compared to that in the D-gal treated group was observed (P < 0.05).
SNX reduced the expression of the activated NF-kB in the brain of D-gal-treated mice
The previous study demonstrated that D-gal activated NF-kB that led to neuroinammation. According to the present immunohistochemistry analysis, the hippocampus NF-kB expression in the D- gal-alone-treated group was signicantly higher than that in the other group (P < 0.05). D-gal induced the increase of NF-kB expression in the hippocampus that was markedly restored by SNX administration (P < 0.05, Fig. 5 ). These results suggest that the antiamnesic effects of SNX may be due to the inhibition of the NF-kB signaling pathway in the hippocampus.
SNX inhibited the activation of astrocytes in the cortex of Dgal-treated mice
To analyze the expression of GFAP, we performed an immunohistochemistry technique. Our results shown in Fig. 5 indicated that the mice in the D-gal-alone-treated group had obviously more GFAP levels in the cortex than those in the control group. SNX signicantly reduced the number of GFAP immunoreactive astrocytes from 45.8 AE 3.2% in the cortex of D-gal-treated mice to 34.5 AE 3.0%, whereas DON (positive control) reduced the same to 36.3 AE 2.7%.
Histopathological examination
Next, we investigated the frontal brain atrophy in D-gal mice. As shown in Fig. 6 , the frontal portion of the cerebrum showed atrophy-prone changes in D-gal mice. Administration with DON and SNX could alleviate the frontal brain atrophy induced by Dgal treatment. Moreover, we observed that the brain weight in the D-gal-alone-treated group decreased. However, there was no signicant difference among all the groups. Histological features of the CA1 region of mice hippocampus are depicted in Fig. 7 . There are no remarkable hippocampal neuronal abnormalities in the control group. CA1 pyramidal cells were arranged neatly and tightly with no noticeable cell loss. Compared with the case of the control group, D-gal induced obvious neuropathological changes in the CA1 region of the hippocampus, and extensively damaged neurons in the hippocampus CA1 region were observed. The CA1 layer neurons showed pronounced shrinkage of their neuronal bodies with their nuclei losing regular outlines and becoming hyperchromatic. However, SNX administration signicantly attenuated the severity of neuronal pathomorphological changes. These data indicate that SNX protects the brain against D-gal induced injury, similar to the effects of DON.
Nissl staining
Nissl body staining is a marker of mature neurons and can be used to detect neuronal apoptosis. As illustrated in Fig. 7 , the Nissl-stained slices of mouse brain showed intense, rich Nissl bodies in the control group, with clearly depicted axons and no obvious abnormalities in neurons. In the D-gal-alone-treated group, Nissl bodies were signicantly reduced in the region of the hippocampus CA1. Treatment with SNX protected the neurons from the D-gal-induced damage. The quantication of Nissl-positive cell densities in the hippocampus was determined, as shown in Fig. 7 . The number of survival neurons in the CA1 region of the hippocampus was reduced in D-gal-treated mice as compared to that in the vehicle-treated mice. Aer SNX and DON treatment, the number of survival neurons signi-cantly increased in the CA1 region of the hippocampus in SNXtreated mice as compared to that in the D-gal-alone-treated group. These ndings indicate that SNX protects against neuronal apoptosis in the hippocampus of D-gal treated mice. 
Discussion
During natural aging, the brain undergoes progressive morphologic and functional changes resulting in the observed behavioral retrogression such as decline in motor and cognitive performance. It will be of signicant value to nd out drugs against neurodegeneration to delay brain senescence. 14 Therefore, we carried out this research to investigate the neuroprotective effect of SNX on the D-gal-induced aging mouse model from the perspective of anti-oxidation, antineuroinammation, and anti-apoptosis.
Oxidative stress plays an important role in the aging process.
15 MDA is a major marker of oxidative damage in cell 19, 20 To further investigate the possible mechanism of SNX in reversing D-gal induced memory decline, the level of caspases-3, one of the major apoptotic mediators, was examined. The present results demonstrate that treatment with SNX can reverse caspase-3 protein expression in the CA1 region, suggesting the anti-apoptotic capability of SNX.
Recent reports demonstrate that D-gal induces astrocyte dysfunction and inammatory response. 21 The increased GFAP expression in the cerebral cortex is an indicator of brain aging. NF-kB, a family of DNA-binding proteins, is activated under physiological and pathological conditions and involved in regulating many aspects of cellular activity in stress, injury, and especially in pathways of inammatory response. 20 Therefore, in the present study, we observed the expression of GFAP in the cerebral cortex and NF-kB in the CA1 region. Interestingly, SNX attenuated a D-gal-mediated decrease in the astrocyte plasticity marker GFAP. The excessive increase in the GFAP expression resulting in astrogliosis implicates inammation, increase in reactive oxygen species, and transition to a neurodegenerative state. 22 Few studies propose the involvement of the transcription factors NF-kB in regulation of the transcription of GFAP. In our present study, the results show that SNX prevents the D-galinduced memory impairment associated with the activation of NF-kB. SNX treatment signicantly reduced the expression of NF-kB as compared to the case of the D-gal administered group; this suggested that SNX could protect the hippocampus from age-induced chronic inammation.
Conclusion
In general, the present study demonstrates the neuroprotective effect of SNX from the results of in vitro and in vivo experiments. SNX can alleviate aging in the mouse brain induced by D-gal by improving behavioral performance, alleviating oxidative stress, inhibiting neuroinammation, and reducing brain cell damage in the hippocampus. SNX may be considered as a novel agent for easing aging and/or age-related neurodegenerative diseases.
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